ABOUT
What We Do
Accuro Technologies is an innovative medical device company dedicated to providing simple solutions to improve patient care.
Our approach is to blend medical expertise with advanced engineering to provide affordable, easy to use, accessible solutions to everyday problems.
Management Team
Accuro founder James Helliwell holds a medical degree from the University of British Columbia, with a specialization in anesthesiology. He also received sub-specialty training in cardiac anesthesiology and transplantation, and board certification in Perioperative Echocardiography. Prior to founding Accuro, he held a clinical practice at a quaternary academic cardiac center in St. Paul’s Hospital, Vancouver. He also served as Clinical Assistant Professor at the University of British Columbia.
Dr. Dolphin completed his Honours Bachelor of Science at the University of Western Ontario in Astronomy and Geophysics. He received his Masters and Doctorate from Stanford University in Aeronautical and Astronautical Engineering. Dr. Dolphin has had a diverse background including work in precision engineering and manufacturing, rocket design, satellite component engineering, geophysics, computer software production, and management of engineering teams on spaceflight projects.
Dr. Malone graduated with High Honors from Harvey Mudd College in Claremont, California with a degree in engineering and was the inaugural PhD student in Stanford's Bioengineering Department. While at Stanford, she received both a National Science Foundation Fellowship and a Stanford BioX Graduate Fellowship. For the past 10 years, Dr. Malone has worked in senior management in small biotech.
Jo Wells studied at Carleton University where she obtained a bachelor's degree in Neuroscience and Mental Health. She worked in a cognitive research lab studying the relation between cognition and sleep deprivation in adolescents using EEG/ERP response waves. Jo also has experience working in the health and safety sector monitoring internal regulatory compliance. Jo's unique background of clinical research and safety monitoring makes her highly adept at her role as a Clinical Coordinator.
Juno spends most of her day making sure that the Accuro team is working hard so she doesn't have to. She demands that projects be delivered on time and on budget,as well as regularly scheduled treats and belly rubs. Juno usually sleeps at her desk (or under it, more specifically), but despite her poor work ethic and lack of technical skills, the staff feel her positive attitude and friendly demeanor make her a delightful addition to the team.
James Helliwell, MD
Michael Dolphin, PhD
Jo Wells, Bsc
Amanda Malone, PhD
Juno
Chief Technology
Officer
Chief Executive
Officer
Clinical Coordinator
Chief Scientific
Officer
Chief Morale Officer
Board of Directors
Simon received his MD from the University of Cape Town. He is an internal medicine specialist with an interest in cardiovascular disease and obtained his PhD through the University of Amsterdam in cardiovascular genetics. He is founder, president and CEO of Xenon Pharmaceuticals Inc., a life sciences company focused on developing innovative therapeutics based on clinically and genetically validated drug targets.
Accuro founder James Helliwell holds a medical degree from the University of British Columbia, with a specialization in anesthesiology. He also received sub-specialty training in cardiac anesthesiology and transplantation, and board certification in Perioperative Echocardiography. Prior to founding Accuro, he held a clinical practice at a quaternary academic cardiac center in St. Paul’s Hospital, Vancouver. He also served as Clinical Assistant Professor at the University of British Columbia.
John Montalbano is Vice Chairman of RBC Wealth Management. John Montalbano holds a Chartered Financial Analyst designation, as well as a Bachelor of Commerce with Honours from UBC. He is a Leslie Wong Fellow of the UBC Portfolio Management Foundation. and also holds an Honorary Doctorate of Letters from Emily Carr University. He has served as CEO of Royal Bank of Canada’s Global Asset Management since 2008 and prior, as President of Phillips, Hager & North Investment Management.
Paul Geyer is CEO of LightIntegra Technology Inc. LightIntegra has developed the ThromboLux technology, which is used as a point of care device to determine platelet quality for blood transfusions. Paul is also Chairman of Neovasc Inc., a new specialty vascular device company. From its inception in 2001 to June 2008, Mr. Geyer held the position of CEO at Medical Ventures and was responsible for raising over $40 million in Equity financing in the Private and Public markets and growing the company
Michael Wilmink is an orthopaedic surgeon practicing in Phoenix, Arizona in private practice with the super-group OrthoArizona. Michael introduced the muscle sparing anterior approach technique for hip replacements to Phoenix in 2007, and he currently lectures and teaches this technique to surgeons across the United States. Dr Wilmink volunteers his time with the Phoenix Thunderbirds to help run the PGA Waste Management Phoenix Open which raises over 9 million dollars per year for charity.
Simon Pimstone
James Helliwell
John Montalbano
Paul Geyer
Michael Wilmink
MD PhD FRCPC, Chairman
MD FRCPC, Director
CFA, Director
Director
MD, Director